Tumour Models London 2022 - FREE TO ATTEND

Conference themes
With next generation of complex immuno-oncology candidates, preclinical and translational scientists in the IO space are in need for more predictive tumour models to improve clinical translatability, accelerating speed-to-clinic with confidence.

We are excited to finally reunite this community in December at 11th PREDiCT: Tumour Models London Summit to address the critical next step of narrowing the preclinical gap and progressing efficacious candidates to the clinic.

Scientific Society
Hanson Wade

Notes
Brochure: https://go.evvnt.com/1278439-3?pid=4832

Speakers: Céline Nicolazzi Group Leader Pharmacology Oncology Sanofi, Antje Margret Wengner Senior Scientist Bayer AG, Aude de Gassart Head of Preclinical Model Development ImCheck Therapeutics

https://go.evvnt.com/1278439-2?pid=4832

Ms. Monica Mojumder Chan